![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Berrebi A., Kobuch W. E., Bessieres M. H., Bloom M. C., Rolland M., Sarramon M. F., Roques C., Fournie A. Termination of pregnancy for maternal toxoplasmosis. Lancet 1994; 344: 36–39
- Flamm H., Aspock H. Die Toxoplasmose‐Uberwachung der Schwangerschaft in Osterreich–Ergebnisse und Probleme. Pädiatrie und Grenzgebite 1981; 20: 27–34
- Foulon W., Naessens A., Volckaert M., Lauwers S., Amy J. J. Congenital toxoplasmosis: a prospective survey in Brussels. British Journal of Obstetrics and Gynaecology 1984; 91: 419–423
- Foulon W., Naessens A., DeCatte L., Amy J. J. Detection of congenital toxoplasmosis by chorionic villus sampling and early amniocentesis. American Journal of Obstetrics and Gxnecotogx 1990; 163: 1511–1513
- Foulon W., Naessens A., Derde M. P. Evaluation of the possibilities for preventing congenital toxoplasmosis. American Journal of Perinatology 1994; 11: 57–62
- Hohlfeld P., Daffos F., Thulliez P., Aufrant C., Couvreur J., Mac Aleese J. Fetal toxoplasmosis: outcome of pregnancy and infant follow‐up after in utero treatment. Journal of Pediatrics 1989; 115: 765–769
- Labadie M. D., Hazemann J. J. Apport des bilans de santé de ľenfant pour le dépistage et ľétude épidémiologique de la toxoplasmose congénitale. Annates de Pediatric 1984; 31: 823–828
- Stray‐Pedersen B., Lorentzen‐Styr A. M. The prevalence of toxoplasma antibodies among 11–736 pregnant women in Norway. Scandinavian Journal of Infectious Diseases 1979; 11: 159–165